Existing Drug Shows Promise Against Deadly Hepatitis E Scientists have discovered that bemnifosbuvir, a drug already in clinical trials for hepatitis C, can effectively block hepatitis E virus replication, potentially providing the first targeted treatment for a neglected disease that kills 70,000 people annually. Hepatitis E infects millions globally